![[Updated] B-2 Spirit Bombers Struck Iranian Nuclear Sites](https://theaviationist.com/wp-content/uploads/2025/06/B2sGuam_2.jpg)
Roche's bispecific-ADC combo keeps cancer at bay in 2nd shot at 2nd-line large B-cell lymphoma
Roche has demonstrated the power of combining two of oncology's hottest modalities—bispecifics and antibody-drug conjugates—in a Lunsumio-Polivy regimen in large B-cell lymphoma.
Roche has demonstrated the power of combining two of oncology's hottest modalities—bispecifics and antibody-drug conjugates—in a Lunsumio-Polivy regimen in large B-cell lymphoma.
